跳至主要内容
临床试验/NCT04314505
NCT04314505Unknown4 期

Opioid-Sparing Protocol Using for Postoperative Pain Management Comparing With Opioid-based Patient Control Analgesia After Simultaneous Bilateral Total Knee Arthroplasty: a Randomized Controlled Trial

Taipei Veterans General Hospital, Taiwan1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2020年3月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
56
试验地点
1
主要终点
Pain scores using numerical rating scale (VAS, 0 to 10) at motion

研究概览

简要总结

The concern for the opioid use in the total knee arthroplasty continues to rise in recent decades. Historically, the total knee arthroplasty consumed high doses opioids in the postoperative periods. Compared to the Opioid-Based patient controlled analgesia(PCA), the opioid-sparing protocol may have benefits to decrease the concerns of the opioid use and opioid-related complication and provides the equivalent efficacy for pain control. The purpose of this trial in to provide a novel opioid-sparing protocol (OSP) to evaluate the efficacy for pain control and reducing the immediate postoperative opioid consumption.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient with bilateral advanced knee osteoarthritis undergoing simultaneous bilateral total knee arthroplasty surgery
  • willing to participate in this study and randomly allocated to either opioid-sparing protocol or PCA protocol.

排除标准

  • patient who refused to participate or with contraindication or hypersensitivity to any of the study drugs
  • chronic pain disorder (exceeding 50 mg oral morphine equivalence per day at time of recruitment)
  • substance abuse (e.g. alcoholism)
  • severe renal impairment.

研究组 & 干预措施

Opioid Sparing Protocol

Experimental

Preemptive(before incision): Parecoxib sodium 40 mg Postoperative: Parecoxib sodium 40 mg was given intravenously every 12 hours for 4 more doses.

干预措施: Opioid-Sparing Protocol (Drug)

Opioid Based Patient Controlled Analgesia

Active Comparator

Preemptive(before incision) and Postoperative: the initial setting was 0.01mg/kg*hour, patient-controlled dose 2 mg, lock-out 5 minutes and limited 40mg in each 4 hours; adjusted by the PCA staff

干预措施: Opioid-Based Patient Controlled Analgesia (Drug)

结局指标

主要结局

Pain scores using numerical rating scale (VAS, 0 to 10) at motion

时间窗: Post-operative 72 hour hours after surgery

Post-operative 72 hours

Pain scores using numerical rating scale (VAS, 0 to 10) at rest

时间窗: Post-operative 72 hours after surgery

Post-operative 72 hours

次要结局

  • maximum angle of continuous passive motion (CPM) as tolerated (Degrees)(0-72 hours after surgery)
  • Satisfaction scale (0-100 points)(postoperative 2 weeks after surgery)
  • Cumulative morphine consumption(mg)(0-72 hours after surgery)
  • Length of hospital stay (LOS) (Days)(After surgery until discharge (about 3-5 days after surgery))
  • drug-related (opioid) adverse events(0-72 hours after surgery)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验